StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly non-GAAP diluted earnings per share ($) ($)

Form 8-K Non-GAAP Reconciliation Schedules

Latest, FY2025
24.21
Period ended Dec 31, 2025
Change on a year earlier
+86.4%
12.99 in FY2024
History
10 years
Since FY2016
Sources
7
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Eli Lilly Non-GAAP diluted earnings per share ($) ($), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/eps_nongaap

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.